Drugs / FLUBROBENGUANE
FLUBROBENGUANE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01085175 | May 2010 → Feb 2011 | heart failure | Lantheus Medical Imaging | Withdrawn | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUBROBENGUANE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4300856 ↗ |
| Known as | Flubrobenguano (18f) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4300856 ↗ |
| Known as | LMI 1195 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01085175 ↗ |
| Modality | Small molecule | — CHEMBL4300856 ↗ |
| Route | Intravenous | “Single bolus intravenous injection of LMI 1195” NCT01085175 ↗ |